Free Trial

ZimVie Q1 2024 Earnings Report

ZimVie logo
$13.85 +0.09 (+0.65%)
(As of 01:00 PM ET)

ZimVie EPS Results

Actual EPS
$0.08
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
$0.25

ZimVie Revenue Results

Actual Revenue
$118.20 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

ZimVie Announcement Details

Quarter
Q1 2024
Time
After Market Closes

Conference Call Resources

How Low-Cost Stocks Generate Monthly Income (Ad)

Are you ready to transform your investment strategy and generate a steady monthly income? We’re excited to offer you our exclusive report, "Options Trading Strategy: 2 (Surprisingly) Low-Cost Stocks Primed for Generating Monthly Income," FREE!

👉 Yes, I Want the Free Report! 👈

ZimVie Earnings Headlines

ZimVie Inc (ZIMV) Gets a Sell from Barclays
ZimVie Reports Third Quarter 2024 Financial Results
Why I'm telling friends to avoid gold stocks
Back in November, gold made a tiny move of 1.6%. But according to my backtesting by using a special type of gold trade, I would have seen a 141% gain in just a week. It happened again in March. Gold nudged up 1.2%. This time? A 104% overnight gain. And in June? A 1% gold move turned into a 74% gain in two weeks. Granted, there would have been smaller wins and those that did not work out, but you see, there's a reason I'm telling all my friends to hold off from buying gold or regular gold stocks right now. There's a more lucrative way to play the gold market as we enter a new breakout period. It's all about catching what I call "Acceleration Cycles."
ZimVie Inc. (ZIMV) Q3 2024 Earnings Call Transcript
See More ZimVie Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like ZimVie? Sign up for Earnings360's daily newsletter to receive timely earnings updates on ZimVie and other key companies, straight to your email.

About ZimVie

ZimVie (NASDAQ:ZIMV), together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment. The company offers dental implant systems, prosthetic and abutment products, surgical instrumentation, and kits; and patient-specific restorative solutions, such as abutments, bars, implant bridges, and hybrid restorations under the BellaTek brand name. It provides bone grafts, barrier membranes, and collagen wound care products; virtual treatment planning services, guided surgery solutions, CAD/CAM workflow systems, and intra-oral scanners; and Implant Concierge, a web-based treatment planning and surgery guide service. In addition, the company designs, manufactures, and distributes spinal fusion implants, instrumentation for various spinal procedures, biologics, and bone healing technologies. Further, it provides MIS solutions that deliver implant and instrumentation systems; and motion preservation solutions that offer non-fusion alternatives for cervical disc implant or growth modulation for anterior vertebral body tethering. The company sells its products to oral surgeons, dental specialists, general dentists, dental laboratories, and other dental organizations, including DSOs, as well as educational, medical, and governmental entities, hospitals, and surgery centers through direct sales representatives, agents, and distributors. ZimVie Inc. was incorporated in 2021 and is headquartered in Westminster, Colorado.

View ZimVie Profile

More Earnings Resources from MarketBeat